Reported cases of chlamydia, gonorrhea, and syphilis declined for the third straight year in 2024, but cases of newborn syphilis were up by 2%.
MAM01 administration was well tolerated, and no treatment-related serious adverse events occurred after 1 or 2 doses.
Timely receipt of MMR1 remained unchanged across the study period, at about 54%.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"Sadly, the ACIP [Advisory Committee on Immunization Practices] we knew has been hijacked and is today an ideological body and no longer a scientific one.”
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
